These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3544199)

  • 1. The protective effect of beta 1-3D-glucan-derivatized plastic beads against Escherichia coli infection in mice.
    Seljelid R; Rasmussen LT; Larm O; Hoffman J
    Scand J Immunol; 1987 Jan; 25(1):55-60. PubMed ID: 3544199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of prostaglandin E2 and interleukin 1 by mouse peritoneal macrophages stimulated with beta-1,3-D-glucan derivatized plastic beads.
    Rasmussen LT; Lipsky PE; Seljelid R
    Scand J Immunol; 1987 Dec; 26(6):731-6. PubMed ID: 3501158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo activation of mouse macrophages with beta-1,3-D-glucan-derivatized plastic beads.
    Seljelid R; Bøgwald J; Rasmussen LT; Larm O; Hoffman J; Berge A; Ugelstad J
    Scand J Immunol; 1985 Jun; 21(6):601-5. PubMed ID: 4023630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamics of blood components and peritoneal fluid during treatment of murine E. coli sepsis with beta-1,3-D-polyglucose derivatives. I. Cells.
    Rasmussen LT; Seljelid R
    Scand J Immunol; 1990 Oct; 32(4):321-31. PubMed ID: 2237287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phagocytosis of beta-1,3-D-glucan-derivatized microbeads by mouse peritoneal macrophages involves three different receptors.
    Konopski Z; Rasmussen LT; Seljelid R; Eskeland T
    Scand J Immunol; 1991 Mar; 33(3):297-306. PubMed ID: 1849314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamics of blood components and peritoneal fluid during treatment of murine E. coli sepsis with beta-1,3-D-polyglucose derivatives. II. Interleukin 1, tumour necrosis factor, prostaglandin E2, and leukotriene B4.
    Rasmussen LT; Fandrem J; Seljelid R
    Scand J Immunol; 1990 Oct; 32(4):333-40. PubMed ID: 2173131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapeutic modification of Escherichia coli--induced experimental peritonitis and bacteremia by glucan.
    Williams DL; Browder IW; Di Luzio NR
    Surgery; 1983 Mar; 93(3):448-54. PubMed ID: 6338616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A soluble beta-1,3-D-glucan derivative potentiates the cytostatic and cytolytic capacity of mouse peritoneal macrophages in vitro.
    Seljelid R; Bøgwald J; Hoffman J; Larm O
    Immunopharmacology; 1984 Feb; 7(1):69-73. PubMed ID: 6715145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmentation of host defense against bacterial infection pretreated intraperitoneally with an alpha-glucan RBS in mice.
    Takeda Y; Yoshikai Y; Ohga S; Nomoto K
    Immunopharmacol Immunotoxicol; 1990; 12(3):457-77. PubMed ID: 2266231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of soluble fungal (1-->3)-beta-D-glucan obtained from Sclerotinia sclerotiorum on alveolar macrophage activation.
    Sakurai T; Ohno N; Suzuki I; Yadomae T
    Immunopharmacology; 1995 Aug; 30(2):157-66. PubMed ID: 8530257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral (1-->3),(1-->4)-beta-D-glucan synergizes with antiganglioside GD2 monoclonal antibody 3F8 in the therapy of neuroblastoma.
    Cheung NK; Modak S
    Clin Cancer Res; 2002 May; 8(5):1217-23. PubMed ID: 12006541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological effects of the immunomodulator beta 1-3D polyglucose are strongly potentiated by conjugation to biodegradable microbeads.
    Seljelid R; Gao Q; Berge A; Ugelstad J
    Scand J Immunol; 1997 Jun; 45(6):683-7. PubMed ID: 9201309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immunomodulatory effect of yeast glucan on delayed hypersensitivity.
    Pérez HA; Bolívar J; San Blas G
    J Immunopharmacol; 1984; 6(4):305-21. PubMed ID: 6527008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of beta-glucan against mycobacterium bovis, BCG infection in BALB/c mice.
    Hetland G; Løvik M; Wiker HG
    Scand J Immunol; 1998 Jun; 47(6):548-53. PubMed ID: 9652822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of beta-glucan against systemic Streptococcus pneumoniae infection in mice.
    Hetland G; Ohno N; Aaberge IS; Lovik M
    FEMS Immunol Med Microbiol; 2000 Feb; 27(2):111-6. PubMed ID: 10640605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different role of serum components and cytokines on alveolar macrophage activation by soluble fungal (1-->3)-beta-D-glucan.
    Sakurai T; Kaise T; Yadomae T; Matsubara C
    Eur J Pharmacol; 1997 Sep; 334(2-3):255-63. PubMed ID: 9369356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFN-gamma inhibits internalization of soluble aminated beta-1,3-D-glucan by macrophages and thereby down-regulates the glucan induced release of TNF-alpha and IL-1 beta.
    Konopski Z; Seljelid R; Eskeland T
    Scand J Immunol; 1994 Jul; 40(1):57-63. PubMed ID: 8029644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenously administered (1----3)-beta-D-glucan, SSG, obtained from Sclerotinia sclerotiorum IFO 9395 augments murine peritoneal macrophage functions in vivo.
    Sakurai T; Ohno N; Yadomae T
    Chem Pharm Bull (Tokyo); 1992 Aug; 40(8):2120-4. PubMed ID: 1423766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β-glucan-coupled superparamagnetic iron oxide nanoparticles induce trained immunity to protect mice against sepsis.
    Pan Y; Li J; Xia X; Wang J; Jiang Q; Yang J; Dou H; Liang H; Li K; Hou Y
    Theranostics; 2022; 12(2):675-688. PubMed ID: 34976207
    [No Abstract]   [Full Text] [Related]  

  • 20. Tissue distribution of intraperitoneally administered (1-->3)-beta-D-glucan (SSG), a highly branched antitumor glucan, in mice.
    Suda M; Ohno N; Adachi Y; Yadomae T
    J Pharmacobiodyn; 1992 Aug; 15(8):417-26. PubMed ID: 1479542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.